Promega
Buying intent
19 tracked signals | Top 15 topics are below | Engineering and Marketing are carrying most of it.
Attention by team
LinkedIn activity, by teamWhere Promega's own people are actually spending their attention, by team, by topic. Bands run Low to High against the busiest pairing on this page, and each cell also shows how much of that team's own activity it represents.
Topics being researched
30-day windowEvery tracked topic, ranked by volume, not by our guess at what matters. Confidence is the classifier's own certainty that a signal belongs where we've filed it.
4d ago
17d ago
14d ago
26d ago
22d ago
4d ago
4d ago
30d ago
18d ago
18d ago
30d ago
22d ago
30d ago
30d ago
4d ago
Need intent for a specific topic or industry?
We track the full taxonomy across every account in the graph — including themes not shown on this page.
Who's active at Promega
verified title on fileTitles, seniority and topic straight from each person's own activity, with a LinkedIn link so you can check any of them yourself.
Primary products / business lines
LinkedIn company profileAt Promega Corporation, creativity and connection drive discovery and innovation. We celebrate scientific discovery and the creative application of science to solve problems. Interactions with our customers, partners and vendors are central to everything we do, and we value those relationships. We seek out and build connections across the globe and in our local communities because creative proble
Top accounts researching Promega
names withheld on the public pageThese are companies whose own people brought up Promega unprompted, not accounts we guessed might be interested. We can't yet tell an implementation partner from a genuine buyer here, names unlock along with the buyer profile below.
1,366 companies · 4,864 people are researching Drug Discovery
Promega's own team shows 2 signals on this topic. No one outside Promega has been seen researching the company by name yet — so this is the market it sits in, not a list of its buyers.
- Artificial Intelligence129,094 cos · 649,540 people
- Aviation Accidents867 cos · 3,062 people
Buyer profile
company size · seniorityCompany size and how senior the people involved are, the two things that decide whether this is a real deal. Competitor overlap isn't computed yet for this account.
Buying committee functions
Employee job titles (LinkedIn)Engineering — 2 people; Product — 1 person; Marketing — 1 person
What's been said
public posts mentioning PromegaUp to 9 public excerpts naming Promega from the past 365 days, across LinkedIn, Reddit, X, YouTube and other public sources.
Agenda has now been finalised for the Promega Maxwell in Focus Day in June. Please register for the event here: https://lnkd.in/ezunZVdA #DNAExtraction , #AutomatedExtraction , #NucleicAcidExtraction , #LongReadSequencing , #OxfordNanopore , #cfDNA (cell-free DNA focus) #TransplantGenomics , #ClinicalGenomics , #Oncology , #CancerGenomics
May 2026JOB OPPORTUNITY! Are you the person that is always helping design and troubleshoot experiments for others as well as yourself? Or like to know how the instrument that is doing all your measurements works? Then being a Technical Services Scientist may be the role for you! We have an opening in the Promega UK team and I’d be happy to discuss the role with those in my network who are interested. PhD desirable, equivalent industrial experience also considered. DM if you'd like more details.
May 2026This was a great blog to be able to write. As a science writer I have been following and writing about PROTACs when they emerged as an area expertise for Promega R&D. It's nice to see the work of the scientific community reaching a place of maturity. The field has moved remarkably quickly.
May 2026FINAL BUZZER at #AAI2026 — TNF (fka TNF-α) is your Cytokine Playoff Champion! The apex node of the inflammatory cytokine network proved it's also the people's champ, showing broad influence in the cascade and on the court. IL-10 fought hard to restore balance, but even immunology's best peacekeeper couldn't cool TNF's rally. Thanks to everyone who stopped by the Promega Corporation booth to vote, talk science, and defend (/trash talk) the competitors. See you all next year! To learn more about Promega's no-wash cytokine immunoassays, visit: https://lnkd.in/gjzFD5pr
Apr 2026Very excited about this Promega-Nimagen partnership in bringing MPS to global forensic labs!
Apr 2026Today, Promega announced a distribution agreement with NimaGen to bring their IDseek® MPS library prep kits to forensic laboratories worldwide. Let me tell you why this matters. For most of my career, the question in forensic DNA has been: when does MPS become routine casework, not just research? The honest answer has always been the same: when the workflow stops being a barrier. NimaGen's RC-PCR technology does something genuinely different. It collapses what has traditionally been a multi-step, error-prone library prep process into a single closed-tube reaction. The result is a workflow that forensic scientists will actually recognize - sensitive, specific, and designed around the realities of degraded and low-quantity samples. Through this agreement, Promega will distribute more than 20 products across seven IDseek product families - covering autosomal STR, Y-STR, SNP, microhaplotype, and mitochondrial DNA. That breadth matters. This isn't a niche add-on. It's a credible MPS portfolio sitting alongside the CE-based tools labs already depend on. What I'm most proud of is what this means for laboratories that have wanted to move toward MPS but couldn't justify the transition cost and complexity. You don't have to change suppliers, rebuild relationships, or start over. You can extend what you already have. The forensic community has earned the right to expect better tools. This is one of them. https://lnkd.in/grZAycmX #ForensicDNA #MPS #HumanIdentification #Promega #NimaGen #ForensicScience #GeneticIdentity
Apr 2026As I leave Promega Corporation today, I find myself reflecting on the last 8+ years, of which there are so many great memories. I’m so thankful for the experiences and opportunities, including visiting five new countries and modernizing the global endpoint management strategies and toolsets. I’m proud to have worked with so many talented people and built so many relationships that I sincerely hope will continue well into the future. Leaving such a place is bittersweet, but I’m excited to start my new chapter on Monday. I look forward to building new relationships, facing new challenges, and growing in ways I can’t yet anticipate - both personally and professionally. Stay tuned for the new adventure!
Apr 2026